NCT06965803Recruiting
This Study is to Evaluate Whether Receiving Education and Glucose Monitoring With the CGM Device Will Improve Patient-reported Outcomes by Improving Patient's Satisfaction and Quality of Life (QOL) With Glucose Monitoring Device
Cedars-Sinai Medical Center
Start Date
10/1/2025
Completion Date
12/30/2026
Summary
The purpose of the study is to improve patient-reported outcomes by improving patient's satisfaction and quality of life (QOL) with glucose monitoring device through pre and post satisfaction survey of patient with diabetes.
Eligibility Criteria
Age Range: 18 years to No maximum
Inclusion Criteria:
* aged 18 or older
* diagnosed with Type 1 or Type 2 Diabetes who are on insulin
* able to speak and understand English language
* scheduled to receive a standard inpatient diabetes education consultation
* must not have used CGM in the six months prior to admission
* owns a smartphone
* demonstrates the ability to follow instructions and be capable of providing informed consent to participate in the program
Exclusion Criteria:
* those who are known to be pregnant. This is due to complexity of pregnancy-related changes in glucose metabolism and increased skin sensitivity, or changes in skin condition to adhesives and materials used in CGM devices.
* non-English speakers. As this is small study to evaluate which method is favorable using a survey only validated in English, enrolling non-English speakers would require additional resources/translations/personnel for evaluation and the education intervention that are not logistically possible right now.
Conditions
Diabetes Mellitus
Locations
Cedars-Sina Medical Center
Los Angeles, California 90048
United States